The Utility of SOX2 and AGR2 Biomarkers as Early Predictors of Tamoxifen Resistance in ER-Positive Breast Cancer Patients

Figure 4

Relationship between SOX2 expression (a), AGR2 expression (b), serum AGR2 level (c), and time-to-failure of tamoxifen treatment (in months) in group 3 (Kaplan-Meier survival curves).

(a)

(b)

(c)